Democratic Republic of Congo
Nearly 92 million people in the Democratic Republic of Congo (DRC) are at risk for one or more neglected tropical diseases (NTDs). The country is endemic for all five NTDs targeted by USAID’s Act to End NTDs | East program: lymphatic filariasis (LF), onchocerciasis, trachoma, schistosomiasis, and soil-transmitted helminth infections. DRC’s national NTD program leads the country’s efforts against these diseases.
Since 2013, USAID has supported DRC’s Ministry of Health (MOH) to reach its NTD control and elimination goals by focusing on the mapping and scale up of mass treatment for trachoma. As a result, DRC has made considerable progress in mapping the country for trachoma. In 2019, the first two health zones met the criteria for stopping mass treatment for trachoma.
In the Democratic Republic of the Congo, Act | East Program activities are implemented by RTI International. The program continues USAID’s focus on the elimination of trachoma from the country, through support for mapping, mass drug administration campaigns, and impact surveys.